Canada Markets open in 5 hrs 27 mins

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
49.83+0.94 (+1.92%)
At close: 1:00PM EST
Sign in to post a message.
  • S
    Stocktargetadvisor
    $IMVT
    Maintains HC Wainwright Buy USD 40 » USD 54
    Maintains SVB Leerink Outperform USD 39 » USD 52
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 51.99
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 52.52
  • Y
    Yahoo Finance Insights
    Immunovant is up 8.03% to 48.51
  • Y
    Yahoo Finance Insights
    Immunovant is up 8.01% to 38.01
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 46.27
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 45.30
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 44.41
  • A
    Akselrod
    I started following "lionstock-aletrs” (Gooogle it - off course without any space or dash in between the words) and their notifications are better than anyone else.
  • Y
    Yahoo Finance Insights
    Immunovant is up 8.17% to 39.33
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 43.54
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 41.42
  • o
    oblon
    I started following "lionstock-aletrs” (Gooogle it - off course without any space or dash in between the words) and their notifications are better than anyone else.
  • A
    Anonymous
    NEW YORK, April 16, 2020 (GLOBE NEWSWIRE) -- Immunovant, Inc. (IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases, today announced the closing of its previously announced underwritten public offering of 9,613,365 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 1,253,917 additional shares of common stock, at a price to the public of $14.50 per share. The aggregate gross proceeds to Immunovant from the offering were approximately $139.4 million, before deducting underwriting discounts and commissions and offering expenses. All of the shares of common stock were sold by Immunovant
  • Y
    Yahoo Finance Insights
    Immunovant is down 7.36% to 35.22
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 39.89
  • A
    Anonymous
    this is a $5 stock
  • A
    Anonymous
    thin volume...can drop on a dime
  • Y
    Yahoo Finance Insights
    Immunovant reached an all time high at 39.38
  • A
    Anonymous
    headed for single digits